Virsti Therapeutics, Inc. — Form D
Virsti Therapeutics, Inc. of STANFORD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-16. The offering totals $3.0M, of which $1.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-04-16
- Form: D
- Accession: 0001856569-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.4M
- Remaining: $1.6M
- Investors: 1
- Date of first sale: 2021-04-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-396171
Issuer
- Name: Virsti Therapeutics, Inc.
- CIK: 0001856569
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 86 PETER COUTTS CIRCLE, STANFORD, CA, 94305
- Phone: 650-804-2133
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jennifer Cochran, Ph.D. | Director | Stanford, CA |
| Allen Ebens, Ph.D. | Director | Stanford, CA |
| Jon Edwards, Ph.D. | Director | Stanford, CA |
| Heath Lukatch, Ph.D. | Director | Redwood City, CA |
| Allen Ebens, Ph.D. | Executive Officer | Stanford, CA |
More